SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 289,544 shares at $28.92 ($8.3M) on 2023-02-07, disclosed to the SEC on 2023-02-09.
Open-market sale of $8.3M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.92 | 4,442 | $128K | 1.6% |
| 2 | $28.92 | 4,442 | $128K | 1.6% |
| 3 | $29.36 | 59,066 | $1.7M | 21.0% |
| 4 | $29.36 | 59,066 | $1.7M | 21.0% |
| 5 | $27.32 | 36,116 | $987K | 12.0% |
| 6 | $27.32 | 36,116 |
| $987K |
| 12.0% |
| 7 | $28.31 | 44,498 | $1.3M | 15.3% |
| 8 | $28.31 | 44,498 | $1.3M | 15.3% |
| 9 | $29.00 | 1,300 | $38K | 0.5% |
| Total | $28.51 avg | 289,544 | $8.3M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |